Cellectis SA/ FR0010425595 /
| 2024-04-17 5:35:19 PM | Chg. -0.015 | Volume | Bid5:40:00 PM | Ask5:40:00 PM | High | Low |
|---|---|---|---|---|---|---|
| 2.345EUR | -0.64% | 40,901 Turnover: 96,656.965 |
2.330Bid Size: 400 | 2.430Ask Size: 50 | 2.400 | 2.310 |
GlobeNewswire
04-10
Cellectis Publishes a Novel Intronic Gene Editing Approach For the Treatment of Inborn Metabolic Dis...
GlobeNewswire
04-08
Cellectis Announces Two Poster Presentations on Novel TALEN® Editing Process for Gene Correction and...
GlobeNewswire
03-14
Allogene Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Business Updat...
GlobeNewswire
01-16
Cellectis announces the drawdown of the second tranche of €15 million under the credit facility agre...
GlobeNewswire
01-04
Allogene Therapeutics and Foresight Diagnostics Announce Partnership to Develop MRD-based In-Vitro D...
GlobeNewswire
01-04
Allogene Therapeutics Announces 2024 Platform Vision to Redefine the Future of CAR T Led by ALPHA3, ...
GlobeNewswire
2023-12-22
Cellectis Reports Results from Shareholders Meeting Held on December 22, 2023
GlobeNewswire
2023-12-09
Allogene Therapeutics Presents Comprehensive Safety Data of Proprietary Lymphodepletion Agent ALLO-6...
GlobeNewswire
2023-12-05
Adaptive Biotechnologies and Collaborators to Present More than 30 Abstracts Demonstrating the Actio...
GlobeNewswire
2023-11-15
Cellectis Announces the execution of the Subsequent Investment Agreement with AstraZeneca
GlobeNewswire
2023-11-06
Cellectis Reports Financial Results for Third Quarter and First Nine Months 2023
GlobeNewswire
2023-11-03
Allogene Therapeutics Presents Preclinical Data on a Novel Allogeneic CAR T Product Candidate Target...
GlobeNewswire
2023-11-03
Allogene Therapeutics Presents Preclinical Data on Next Generation Cloak™ and Dagger™ Technologies a...
GlobeNewswire
2023-11-02
Cellectis to Present Preliminary Results of NATHALI_01 and Updated Results of the BALLI_01 Phases I ...
GlobeNewswire
2023-11-02
Allogene Therapeutics Reports Third Quarter 2023 Financial Results and Business Update
GlobeNewswire
2023-11-02
Allogene Therapeutics Announces Poster Presentations at the 65th Annual Meeting of the American Soci...
GlobeNewswire
2023-11-01
Cellectis to Report Third Quarter 2023 Financial Results on November 6, 2023
GlobeNewswire
2023-11-01
Cellectis Announces Strategic Collaboration and Investment Agreements with AstraZeneca
GlobeNewswire
2023-10-31
Cellectis Presents Pre-Clinical Data on Multi-armored Allogeneic MUC1-CAR T-cells Targeting Triple-N...
GlobeNewswire
2023-10-24
Cellectis to Present Pre-Clinical Data on HSPC Gene Therapy Program and Comprehensive Analysis of TA...
GlobeNewswire
2023-10-12
Cellectis and Imagine Institute Publish A Proof-Of-Concept Study of a Gene Surgery Candidate to Trea...
GlobeNewswire
2023-09-27
Cellectis to Present Pre-Clinical Data on Multi-armored Allogeneic MUC1-CAR T-cells Targeting Triple...
